Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Certified by Founder
Lodge
DiligenceSquared (YC F25)
start up
United States
- San Francisco
- 10/03/2026
- Seed
- $5,000,000
At DiligenceSquared, we enable leading investors and corporates to make critical investment decisions with confidence through AI-powered market research and commercial due diligence. Our platform uses a network of AI agents to conduct expert interviews, synthesize insights, and produce fully auditable reports.
- Industry Market Research
- Website https://www.diligencesquared.com/
- LinkedIn https://www.linkedin.com/company/diligencesquared/
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)